About SHL Telemedicine
SmartHeart® is developed by SHL Telemedicine, which runs the telemedicine center behind every recording.
| Company | SHL Telemedicine Ltd. U.S. operations: SHL Telemedicine USA, Inc., Hauppauge, New York. |
|---|---|
| Experience | 25+ years in telemedicine and remote cardiac care. |
| Scale | 55K+ SmartHeart® users worldwide and 1M+ ECGs delivered (as stated by SHL). |
| Stock listing | Ordinary shares listed on the SIX Swiss Exchange (SHLTN) since November 15, 2000. |
| FDA | SmartHeart® 510(k) K113514, cleared February 22, 2012. Device & safety information. |
What SHL does
SHL develops personal telemedicine devices and runs a telemedicine center where trained staff review incoming ECGs around the clock. With SmartHeart®, every recording gets a human preliminary review, and a U.S. board-certified cardiologist read is available on request, returned in 30 minutes or less.